Text Size

Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

This study has been completed.
Sponsor:
Information provided by:
Cantonal Hospital of St. Gallen
ClinicalTrials.gov Identifier:
NCT01249534
First received: November 29, 2010
Last updated: December 9, 2010
Last verified: November 2010
History of Changes
  Purpose

Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.


Condition Intervention
Given Indication for Gastroesophageal Cancer Surgery
 Other: gastroesophageal cancer surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Cantonal Hospital of St. Gallen:

Primary Outcome Measures:
  • postoperative Inflammatory complications [ Time Frame: 30 days postoperatively ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: December 2010
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients after gastroesophageal cancer surgery Other: gastroesophageal cancer surgery
gastroesophageal cancer surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Given indication for gastroesophageal cancer surgery

Criteria

Inclusion Criteria:

  • all patients with gastroesophageal cancer surgery

Exclusion Criteria:

  • lack of measurement of C-reactive protein
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01249534

Locations
Switzerland
Department of surgery
St. Gallen, Switzerland, 9007
Sponsors and Collaborators
Cantonal Hospital of St. Gallen
Investigators
Principal Investigator: Rene Warschkow, MD Cantonal Hospital St. Gallen
  More Information

No publications provided

Responsible Party: Rene Warschkow, MD, Kantonal Hospital St. Gallen, Department of Visceral Surgery
ClinicalTrials.gov Identifier: NCT01249534     History of Changes
Other Study ID Numbers: EKSG10/144
Study First Received: November 29, 2010
Last Updated: December 9, 2010
Health Authority: Switzerland: Ethikkommission

ClinicalTrials.gov processed this record on May 21, 2013